These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38945311)

  • 1. Genes for endosomal pH regulators NHE6 and NHE9 are dysregulated in the substantia nigra in Parkinson's disease.
    Prasad H
    Gene; 2024 Nov; 927():148737. PubMed ID: 38945311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Na+/H+ exchanger NHE6 modulates endosomal pH to control processing of amyloid precursor protein in a cell culture model of Alzheimer disease.
    Prasad H; Rao R
    J Biol Chem; 2015 Feb; 290(9):5311-27. PubMed ID: 25561733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of Christianson Syndrome Na
    Pescosolido MF; Ouyang Q; Liu JS; Morrow EM
    J Neurosci; 2021 Nov; 41(44):9235-9256. PubMed ID: 34526390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid clearance defect in ApoE4 astrocytes is reversed by epigenetic correction of endosomal pH.
    Prasad H; Rao R
    Proc Natl Acad Sci U S A; 2018 Jul; 115(28):E6640-E6649. PubMed ID: 29946028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sodium-hydrogen exchanger 6 (NHE6) deficiency leads to hearing loss, via reduced endosomal signalling through the BDNF/Trk pathway.
    Kucharava K; Brand Y; Albano G; Sekulic-Jablanovic M; Glutz A; Xian X; Herz J; Bodmer D; Fuster DG; Petkovic V
    Sci Rep; 2020 Feb; 10(1):3609. PubMed ID: 32107410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repulsive Guidance Molecule a (RGMa) Induces Neuropathological and Behavioral Changes That Closely Resemble Parkinson's Disease.
    Korecka JA; Moloney EB; Eggers R; Hobo B; Scheffer S; Ras-Verloop N; Pasterkamp RJ; Swaab DF; Smit AB; van Kesteren RE; Bossers K; Verhaagen J
    J Neurosci; 2017 Sep; 37(39):9361-9379. PubMed ID: 28842419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
    Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
    Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging links between endosomal pH and cancer.
    Ko M; Quiñones-Hinojosa A; Rao R
    Cancer Metastasis Rev; 2020 Jun; 39(2):519-534. PubMed ID: 32253638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive nigrostriatal terminal dysfunction and degeneration in the engrailed1 heterozygous mouse model of Parkinson's disease.
    Nordströma U; Beauvais G; Ghosh A; Pulikkaparambil Sasidharan BC; Lundblad M; Fuchs J; Joshi RL; Lipton JW; Roholt A; Medicetty S; Feinstein TN; Steiner JA; Escobar Galvis ML; Prochiantz A; Brundin P
    Neurobiol Dis; 2015 Jan; 73():70-82. PubMed ID: 25281317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression profiling of substantia nigra in Parkinson disease, progressive supranuclear palsy, and frontotemporal dementia with parkinsonism.
    Hauser MA; Li YJ; Xu H; Noureddine MA; Shao YS; Gullans SR; Scherzer CR; Jensen RV; McLaurin AC; Gibson JR; Scott BL; Jewett RM; Stenger JE; Schmechel DE; Hulette CM; Vance JM
    Arch Neurol; 2005 Jun; 62(6):917-21. PubMed ID: 15956162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A potential gain-of-function variant of SLC9A6 leads to endosomal alkalinization and neuronal atrophy associated with Christianson Syndrome.
    Ilie A; Gao AYL; Boucher A; Park J; Berghuis AM; Hoffer MJV; Hilhorst-Hofstee Y; McKinney RA; Orlowski J
    Neurobiol Dis; 2019 Jan; 121():187-204. PubMed ID: 30296617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo imaging of neuromelanin in Parkinson's disease using 18F-AV-1451 PET.
    Hansen AK; Knudsen K; Lillethorup TP; Landau AM; Parbo P; Fedorova T; Audrain H; Bender D; Østergaard K; Brooks DJ; Borghammer P
    Brain; 2016 Jul; 139(Pt 7):2039-49. PubMed ID: 27190023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential Alterations in Metabolism and Proteolysis-Related Proteins in Human Parkinson's Disease Substantia Nigra.
    Grünblatt E; Ruder J; Monoranu CM; Riederer P; Youdim MB; Mandel SA
    Neurotox Res; 2018 Apr; 33(3):560-568. PubMed ID: 29218503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease duration and the integrity of the nigrostriatal system in Parkinson's disease.
    Kordower JH; Olanow CW; Dodiya HB; Chu Y; Beach TG; Adler CH; Halliday GM; Bartus RT
    Brain; 2013 Aug; 136(Pt 8):2419-31. PubMed ID: 23884810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Christianson syndrome-linked deletion mutation (∆(287)ES(288)) in SLC9A6 disrupts recycling endosomal function and elicits neurodegeneration and cell death.
    Ilie A; Gao AY; Reid J; Boucher A; McEwan C; Barrière H; Lukacs GL; McKinney RA; Orlowski J
    Mol Neurodegener; 2016 Sep; 11(1):63. PubMed ID: 27590723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular and molecular pathophysiology in the progression of Parkinson's disease.
    Zaman V; Shields DC; Shams R; Drasites KP; Matzelle D; Haque A; Banik NL
    Metab Brain Dis; 2021 Jun; 36(5):815-827. PubMed ID: 33599945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-Expression of Nogo-A in Dopaminergic Neurons of the Human Substantia Nigra Pars Compacta Is Reduced in Parkinson's Disease.
    Eyer GC; Di Santo S; Hewer E; Andereggen L; Seiler S; Widmer HR
    Cells; 2021 Nov; 10(12):. PubMed ID: 34943877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Christianson syndrome protein NHE6 modulates TrkB endosomal signaling required for neuronal circuit development.
    Ouyang Q; Lizarraga SB; Schmidt M; Yang U; Gong J; Ellisor D; Kauer JA; Morrow EM
    Neuron; 2013 Oct; 80(1):97-112. PubMed ID: 24035762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low Levels of Prohibitin in Substantia Nigra Makes Dopaminergic Neurons Vulnerable in Parkinson's Disease.
    Dutta D; Ali N; Banerjee E; Singh R; Naskar A; Paidi RK; Mohanakumar KP
    Mol Neurobiol; 2018 Jan; 55(1):804-821. PubMed ID: 28062948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of siRNA-induced silencing of cellular prion protein on tyrosine hydroxylase expression in the substantia nigra of a rat model of Parkinson's disease.
    Wang X; Yang HA; Wang XN; Du YF
    Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27173342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.